A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia

NCT07064486 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

477

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes (T2DM)

Interventions

DRUG: BGM0504
DRUG: BGM0504
DRUG: Semaglutide

Sponsor

BrightGene Bio-Medical Technology Co., Ltd.